Promising clinical outcomes of nano-curcumin treatment as an adjunct therapy in hospitalized COVID-19 patients: A randomized, double-blinded, placebo-controlled trial.
Phytother Res
; 37(8): 3631-3644, 2023 Aug.
Article
in En
| MEDLINE
| ID: mdl-37118944
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Curcumin
/
COVID-19
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Year:
2023
Type:
Article